Vidya Ramakrishnan

United Kingdom

Writer at Investopedia

markets, stocks and trades

Featured in: Favicon

investopedia.com Favicon

msn.com

wiley.com

yahoo.com (+4) Favicon

flipboard.com Favicon

yourstory.com Favicon

investors.com Favicon

einnews.com Favicon

newsbreak.com Favicon

inkl.com + 2 more

Articles

China Sector Leader Holds Its Own Vs. Nvidia, Palantir

1 week ago | investors.com | Vidya Ramakrishnan

Futu Holdings (FUTU) stock boasts a gain of 54% year to date and steady sales and earnings growth over the past four quarters. That has earned the China-based financial firm a spot in the Investor's Business Daily's Sector Leaders list. American depositary shares of Futu started trading on the Nasdaq in March 2019 at 12. Now Futu is holding its…
Liver Drug Stock Rockets 236% Amid FDA Approval As Sales Accelerate; Funds Load Up

1 week ago | investors.com | Vidya Ramakrishnan

Mirum Pharmaceuticals (MIRM) is building a cup base with a buy point of 54.23, and the biotech stock has cleared an early entry at 49 in the base. Since this is an early stage base that can net higher gains, Mirum Pharmaceuticals is Tuesday's selection for IBD 50 Stocks To Watch. The relative strength line is beginning to rise and…
Liver Drug Stock Rockets 236% Amid FDA Approval As Sales Accelerate; Funds Load Up

1 week ago | inkl.com | Vidya Ramakrishnan

Mirum Pharmaceuticals is building a cup base with a buy point of 54.23, and the biotech stock has cleared an early entry at 49 in the base. Since this is an early stage base that can net higher gains, Mirum Pharmaceuticals is Tuesday's selection for IBD 50 Stocks To Watch. The is beginning to rise and shows that the stock is performing better than the benchmark S&P 500. Year to date, Mirum stock had gained 22% as of Monday vs. the S&P 500 which has just started venturing into positive territory.
CoreWeave Leads Four Stocks Near Buy Points; One Is Also An Nvidia Partner

2 weeks ago | investors.com | Vidya Ramakrishnan

The stock market has rallied sharply from its April lows. That has brought tech and biotech leaders back in large numbers in Investor's Business Daily's IBD 50 list of growth stocks, including top-ranked CoreWeave (CRWV), which recently staged its initial public offering. Several have surged in bases and a few are setting up near buy points. Some of these stocks…
Coinbase Falls To Key Level: Is Coin Stock A Buy Or Sell Now?

2 weeks ago | investors.com | Vidya Ramakrishnan

Coinbase (COIN) fell to a key support level on Tuesday. Is Coinbase stock a buy or sell now? Some may be tempted to buy the stock as it tests support, but investors should examine key chart features and technical indicators and look for proper buy points. Shares leaped 24% on May 13 after news that Coinbase would be the first cryptocurrency…
Cyber Stock Trounces S&P 500 As AI Agents Spur Huge Insider Threats

2 weeks ago | investors.com | Vidya Ramakrishnan

Artificial intelligence stock CyberArk Software (CYBR) is just above a buy zone from a buy point of 375.75. Shares are trying to get past the 400 level after breaking out of a third-stage cup with handle base, according to IBD MarketSurge. CyberArk stock is Tuesday's selection for IBD 50 Stocks To Watch. Shares fell after first-quarter results on May 13…
Cyber Stock Trounces S&P 500 As AI Agents Spur Huge Insider Threats

2 weeks ago | inkl.com | Vidya Ramakrishnan

Artificial intelligence stock CyberArk Software is just above a buy zone from a buy point of 375.75. Shares are trying to get past the 400 level after breaking out of a third-stage cup-with-handle base, according to IBD MarketSurge. CyberArk stock is Tuesday's selection for IBD 50 Stocks To Watch. Shares fell after first-quarter results on May 13 and carved the handle. Earnings per share of 98 cents increased 31% from the prior year and sales grew 43% to $317.6 million.
Indexes Steady Amid Trade Talks; Tesla Jumps Ahead Of Robotaxi Day

2 weeks ago | investors.com | Vidya Ramakrishnan

It was almost all quiet on the Western front as stock indexes on Monday stayed their course against a backdrop of trade negotiations in London between the world's two largest economies. Notably, apart from some early vacillation, the S&P 500 defended the 6000 level on the stock market today. The level has been on investors' watch since late February. The…
Gold Stock Touches Highs With Production Set To Double

3 weeks ago | investors.com | Vidya Ramakrishnan

Gold stock Orla Mining (ORLA) recently broke out of a base with a buy point of 11.95 amid a five-day winning streak, but quickly retreated Friday when the sector hit a downturn due to a strengthening U.S. dollar. Orla was in is a second-stage consolidation base that could net higher gains, especially if gold investing continues to hold its luster…
Biotech Stock Vaults 40% Amid 'Promising' Clinical Trial; Earnings Seen Tripling After It Hits $1 Billion Sales Milestone

3 weeks ago | investors.com | Vidya Ramakrishnan

Cancer treatment company BeiGene renamed itself as BeOne Medicines (ONC) soon after the company achieved a sales milestone. Now, the biotech company is Thursday's selection for IBD 50 Stocks To Watch. With significant operations in the U.S. and China, BeOne changed its stock ticker from BGNE to ONC on Jan. 2. Positive clinical trial results have lifted shares of the…